Company intelligence / Profile preview

KPP

Ownership: Private
Development stage: Commercial

Overview

KP Pharmaceutical Technology provides comprehensive cGMP drug development services including formulation development, analytical testing, clinical trial material manufacturing, and commercial-scale production. The company is US FDA registered and inspected, DEA registered for controlled substances research/manufacturing, and EU cGMP compliant. It has supported hundreds of drug products through various phases but does not have its own proprietary clinical pipeline.

Modalities: Small moleculeBiologicAntibody-drug conjugateVaccine
Industry: Contract Manufacturing Organization

Drug pipeline

1 asset

AVAC ASF Live Vaccine

Commercial

Indications: African Swine Fever

Partnerships

Not specifically listed; collaborates broadly with pharmaceutical industry clients as a CDMO/CRO partner

Beyond the preview

Go deeper on KPP.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KPP.

Explore the full profile